Nuveen Asset Management, LLC Deciphera Pharmaceuticals, Inc. Transaction History

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$13.58 - $17.36 $169,519 - $216,704	12,483 Added 0.88%	1,425,282 $22.4 Million
Q4 2023 Feb 14, 2024	BUY	$10.11 - $16.54 $992,741 - $1.62 Million	98,194 Added 7.47%	1,412,799 $22.8 Million
Q3 2023 Nov 14, 2023	SELL	$12.46 - $15.48 $497,901 - $618,580	-39,960 Reduced 2.95%	1,314,605 $16.7 Million
Q2 2023 Aug 14, 2023	BUY	$13.28 - $15.96 $445,530 - $535,442	33,549 Added 2.54%	1,354,565 $19.1 Million
Q1 2023 May 15, 2023	BUY	$14.26 - $22.1 $6.42 Million - $9.96 Million	450,516 Added 51.75%	1,321,016 $20.4 Million
Q4 2022 Feb 14, 2023	BUY	$14.85 - $19.04 $844,237 - $1.08 Million	56,851 Added 6.99%	870,500 $14.3 Million
Q3 2022 Nov 14, 2022	BUY	$12.38 - $20.23 $8.29 Million - $13.6 Million	669,851 Added 465.83%	813,649 $15.1 Million
Q2 2022 Aug 15, 2022	BUY	$9.11 - $13.98 $155,279 - $238,289	17,045 Added 13.45%	143,798 $5.18 Million
Q1 2022 May 16, 2022	BUY	$6.87 - $11.11 $10,552 - $17,064	1,536 Added 1.23%	126,753 $4.56 Million
Q4 2021 Feb 14, 2022	SELL	$7.7 - $37.13 $149,857 - $722,624	-19,462 Reduced 13.45%	125,217 $4.51 Million
Q3 2021 Nov 12, 2021	SELL	$26.46 - $37.15 $192,575 - $270,377	-7,278 Reduced 4.79%	144,679 $4.77 Million
Q2 2021 Aug 16, 2021	SELL	$32.73 - $47.95 $314,437 - $460,655	-9,607 Reduced 5.95%	151,957 $3.03 Million
Q1 2021 May 17, 2021	SELL	$40.39 - $56.73 $800,772 - $1.12 Million	-19,826 Reduced 10.93%	161,564 $3.22 Million
Q4 2020 Feb 16, 2021	SELL	$51.77 - $66.18 $20,863 - $26,670	-403 Reduced 0.22%	181,390 $3.62 Million
Q3 2020 Nov 16, 2020	SELL	$43.8 - $58.16 $27,462 - $36,466	-627 Reduced 0.34%	181,793 $3.63 Million
Q2 2020 Aug 14, 2020	BUY	$37.05 - $65.03 $2.86 Million - $5.01 Million	77,103 Added 73.21%	182,420 $3.64 Million
Q1 2020 May 14, 2020	SELL	$33.63 - $69.4 $2.05 Million - $4.22 Million	-60,840 Reduced 36.62%	105,317 $4.34 Million
Q4 2019 Feb 14, 2020	SELL	$31.7 - $69.93 $4.31 Million - $9.52 Million	-136,104 Reduced 45.03%	166,157 $10.3 Million
Q3 2019 Nov 14, 2019	BUY	$19.95 - $38.85 $5.04 Million - $9.81 Million	252,553 Added 508.07%	302,261 $10.3 Million
Q2 2019 Aug 15, 2019	BUY	$21.05 - $26.21 $1.05 Million - $1.3 Million	49,708 New	49,708 $1.12 Million

Others Institutions Holding DCPH

# of Institutions

Shares Held

293K

Call Options Held

500

Put Options Held

View Full List

About Deciphera Pharmaceuticals, Inc.

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

More about DCPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account